News | Brachytherapy Systems, Women's Healthcare | October 23, 2019

Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform

Non-invasive accelerated partial breast irradiation solution provides real-time image guidance and targeting confidence for breast brachytherapy

Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform

October 23, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost, announced the latest upgrades to the AccuBoost Digital platform. AccuBoost Digital leverages the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and targeting confidence in the delivery of accelerated partial breast irradiation (APBI) in patients opting for breast conserving therapy (BCT). These upgrades improve the treatment workflow, patient experience and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100 percent adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.

Adaptive therapy allows doctors the ability to alter the treatment plan based on tumor bed and anatomical changes as presented each day at the time of treatment. With AccuBoost Digital, doctors can locate the tumor bed in real time, and adjust the field size, shape and position as needed, while minimizing dose to a patients’ heart, lungs and healthy tissues. 

“If breast cancer patients could talk to their peers that are about to embark on a course of radiation therapy, they would readily be sold on AccuBoost. It is such a well-tolerated procedure. AccuBoost is the only option that we offer for APBI,” said Leann Smith, M.D., radiation oncologist at Cancer Centers of Southwest Oklahoma in Lawton, Okla.

For more information: www.accuboost.com

Related Content

In connection with the collaboration, Elekta has committed to make an investment in ViewRay representing approximately 9.9 percent of the shares of ViewRay’s common stock
News | Radiation Therapy | December 13, 2019
December 13, 2019 — Elekta announced that the company has sign
UFHPTI expands its proton therapy capacity and treatment range with the Proteous One
News | Radiation Therapy | December 12, 2019
December 12, 2019 — IBA (Ion Beam Applications SA) announced that

Image courtesy of Elekta 

News | Radiation Therapy | December 11, 2019
December 11, 2019 — A new clinical guideline from the American Soci...
RaySearch Laboratories AB (publ) has experienced strong growth in recent years, creating the need for larger and more efficient premises
News | Radiation Therapy | December 09, 2019
December 9, 2019 — Karin Gedda, architect and i
radiation therapy non-Hodgkin's lymphoma
News | Radiation Oncology | December 09, 2019
December 9, 2019 — Most people diagnosed with the most common type of non-Hodgkin's lymphoma can safely skip radiatio